FOUNDATION RESOURCE MANAGEMENT INC
EndowmentPosition in BMY — Bristol Myers Squibb Co
CIK 1179232
LITTLE ROCK, AR
Position in BMY
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$9,894,275
-$164,770 QoQ
Shares Held
171,716
+3.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
1.64%
of 13F equity value
Holder Rank
#390
of 2,506 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FOUNDATION RESOURCE MANAGEMENT INC holds $80,220,075 across 6 Drug Manufacturers - General names. BMY ranks #4 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
202,690 | $26,045,665 | |
| 2 | PFE |
Pfizer Inc
|
936,078 | $22,540,758 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
102,147 | $12,905,251 | |
| 4 | BMY |
Bristol Myers Squibb Co
This page
|
171,716 | $9,894,275 | |
| 5 | NVO |
Novo Nordisk A S
|
177,838 | $8,525,553 | |
| 6 | JNJ |
Johnson & Johnson
|
1,215 | $308,573 |
All Filings in BMY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,894,275 | 171,716 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $10,059,045 | 165,854 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $8,406,009 | 155,840 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $6,946,978 | 154,035 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $7,083,018 | 153,014 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $9,327,505 | 152,935 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $8,852,714 | 156,519 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $8,138,288 | 157,292 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $6,528,474 | 157,199 | Shares | Sole | 2024-07-10 | |
| No filing history on record for this holder in this stock. | ||||||